The common types of molecular diagnostic tests include PCR, RT-PCR, DNA microarrays and next generation sequencing. Such tests play a crucial role in healthcare by providing timely and accurate information for medical decision-making. Molecular diagnostic solutions are essential tools for screening, diagnosing, and monitoring diseases, ultimately contributing to improved patient outcomes and public health.

According to Roots Analysis, the molecular diagnostics market size was valued at USD 15.9 billion in 2024 and likely to hit over USD 30.9 billion by 2035, growing at a CAGR of 6.2% during the forecast period 2024 to 2035

By test type, the laboratory testing segment is expected to account for the largest share of the global molecular diagnostics market

It is worth mentioning that the point-of-care testing segment is expected to grow at a higher CAGR compared to laboratory testing market owing to their ability to deliver rapid test results and offer improved convenience and accessibility.

By type of offering, reagents hold a significant market share during the forecast period

The large share of reagents in the molecular diagnostics market is likely due to the fact that the reagents are required to be replenished frequently, thus generating a recurring stream of revenue for the companies.

By sample type, the blood, serum and plasma segment is expected to account for the largest share of the global molecular diagnostics market

It is worth mentioning that the urine sample segment is expected to grow at a higher CAGR compared to the market for other samples owing to their involvement in a number of infectious diseases and genetic diseases.

By type of technology, the PCR segment led the global molecular diagnostics market

The PCR segment occupies the highest share (41%) in 2024 and is expected to witness substantial growth during the forecast period. This is followed by next generation sequencing segment which occupies the second largest molecular diagnostics market share.

By therapeutic areas, infectious disease segment is anticipated to capture the largest share of the global molecular diagnostics market

The market growth of the molecular diagnostics market is expected to be driven by the increasing prevalence of chronic disorders, leading to a CAGR of 6.2% over the forecast period. In terms of therapeutic areas, molecular diagnostic solutions intended for infectious diseases currently capture the majority (42.8%) of the market share.

By end users, hospitals segment is anticipated to capture the largest share of the global molecular diagnostics market

Hospitals are expected to hold the majority molecular diagnostics market share (48%) in 2024 and this trend is expected to continue till 2035, whereas the laboratories segment is expected to grow at the highest growth rate of 6.5%, compared to other segments.

Molecular Diagnostics Market Regional Analysis

North America is expected to dominate the molecular diagnostics market. In recent years, technological advancements have resulted in a tremendous increase in the adoption of molecular diagnostic solutions across various healthcare settings. This indicates that North America plays a significant role in the global molecular diagnostics market and showcases the need for companies to focus on this region in order to capitalize on the growing demand for molecular diagnostic solutions.

Asia is a key region for the with countries like China, Japan, South Korea, and India playing a central role. It is worth highlighting that, in the coming years, owing to the anticipated increase in the demand for molecular diagnostic solutions, the market in Asia is likely to grow at a healthy CAGR during the forecast period.

Key Market Players

Abbott Laboratories, Agilent Technologies, Becton Dickinson, BGI Genomics, bioMrieux, Bio-Rad, Danaher, DiaSorin, Grifols, Hologic, Illumina, Qiagen, QuidelOrtho, Revvity, Roche, Sansure, Seegene, Siemens Healthineers, Sysmex, Thermo Fisher Scientific

Key Segments:

by Test Type

Laboratory Testing

Point-of-Care Testing

by Type of Offering

Reagents

Instruments

Services

by Type of Sample

Blood, Serum and Plasma

Urine

Others

by Type of Technology

PCR

In situ Hybridization

Isothermal Nucleic Acid Amplification Technology

Next Generation Sequencing

Microarrays

Mass Spectrometry

Others

by Therapeutic Area

Cardiovascular Diseases

Genetic Diseases

Infectious Diseases

Neurological Disease

Oncological Disorders

Others

by End Users

Hospitals

Laboratories

Others

by Geographical Regions

North America

Europe

Asia

Latin America

Middle East and North Africa

Rest of the World

About Roots Analysis

Roots Analysis is a global leader in the market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

Contact Details

Gaurav Chaudhary

+1 (857) 387 7999
+44 (748) 188 1310

Email: sales@rootsanalysis.com